Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer | SpringerLink
Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer | BMC Cancer | Full Text
Molecular characterization of non-small cell lung cancer tumors in Latin American patients from Brazil, Chile and Peru uncovers novel potentially driver mutations | medRxiv
Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis - Liu - 2020 - Cancer Communications - Wiley Online Library
Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors | bioRxiv
Lung Cancer - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma | Communications Biology
EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling | Cell Death & Disease
Cancers | Free Full-Text | Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy
IJMS | Free Full-Text | The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
Immunological analysis of 98 lung adenocarcinomas by targeted gene... | Download Scientific Diagram
Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan‐cancer analysis - Liu - 2020 - Cancer Communications - Wiley Online Library
Novel serum biomarkers for lung cancer early diagnosis and clinical outcome
Precision Medicine in Lung Cancer: Challenges and Opportunities in Diagnostic and Therapeutic Purposes | IntechOpen
Frontiers | mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells | Scientific Reports
PTEN/MMAC1 mutations found in lung cancers | Download Table
Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives | Cell Physiol Biochem
Frontiers | Case Report: Recombinant Human Endostatin Plus Chemotherapy for Epidermal Growth Factor Receptor-Negative Miliary Lung Adenocarcinoma
PDF) Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: A retrospective analysis
Proteomic and Phosphoproteomic Analyses Reveal the Oncogenic Role of PTK7-NDRG1 Axis in Non-small-cell Lung Cancer Cell Resistance to AZD9291 | ACS Chemical Biology
Frontiers | Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I–III Non-small Cell Lung Cancer Patients
Clinical Utility of Targeted Sequencing in Lung Cancer: Experience From an Autonomous Swedish Health Care Center
Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells - ScienceDirect
Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer | Molecular Medicine | Full Text
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing - ScienceDirect
IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization - ScienceDirect
